NCT01863134View on ClinicalTrials.gov

Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up

PHASE4CompletedINTERVENTIONAL

Enrollment

140

Participants

Timeline

Start Date

January 31, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions

Non ST Elevation Myocardial Infarction

Interventions

DRUG

Eptifibatide

DRUG

Placebo

Trial Locations (6)

Unknown

Albert Einstein College of Medicine, New York

Center for Cardiovascular Research and Development, American Heart of Poland, Katowice

Department of Internal Medicine and Clinical Pharmacology, Katowice

First Department of Cardiology, Medical University of Silesia, Katowice

Division of Molecular Biology and Clinical Genetics, Jagiellonian University Medical College, Krakow

40-635

First Department of Cardiac Surgery, Medical University of Silesia, Katowice

All Listed Sponsors

lead

Medical University of Silesia

OTHER

NCT01863134 - Clinical Effects of Eptifibatide Administration in High Risk Patients Presenting With Non-ST Segment Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Urgent Coronary Artery Bypass Graft Surgery in Short- and Long-Term Follow-up | Biotech Hunter | Biotech Hunter